Clinical and brain volumetric correlates of decreased DTI-ALPS, suggestive of local glymphatic dysfunction, in iRBD

dc.contributor.authorRoura, Ignacio
dc.contributor.authorPardo, Jèssica
dc.contributor.authorMartín Barceló, Cristina
dc.contributor.authorFalcón Falcón, Carles Maria
dc.contributor.authorOltra González, Javier
dc.contributor.authorCampabadal Delgado, Anna
dc.contributor.authorBargalló Alabart, Núria
dc.contributor.authorSerradell, Mónica
dc.contributor.authorMayà Casalprim, Gerard
dc.contributor.authorMontini, Angelica
dc.contributor.authorPont Sunyer. Claustre
dc.contributor.authorGaig Ventura, Carles
dc.contributor.authorBuongiorno, Maria Teresa
dc.contributor.authorJunqué i Plaja, Carme, 1955-
dc.contributor.authorIranzo, Alex
dc.contributor.authorSegura i Fàbregas, Bàrbara
dc.date.accessioned2026-02-16T17:43:32Z
dc.date.available2026-02-16T17:43:32Z
dc.date.issued2025-04-23
dc.date.updated2026-02-16T17:43:32Z
dc.description.abstractGlymphatic alterations may underlie neurodegeneration in alpha-synucleinopathies. Reduced Diffusion-Tensor Imaging ALong the Perivascular Space (DTI-ALPS), a proxy of perivascular glymphatic activity, has been scarcely studied in isolated REM sleep behaviour disorder (iRBD), a prodromal synucleinopathy stage. Furthermore, its associations with clinical symptoms and brain structural abnormalities remain unexplored. We assessed the DTI-ALPS in sixty-two patients with iRBD and twenty-three healthy controls (HC), exploring its associations with clinical symptoms, cortical thickness and brain volumetric data. iRBD patients exhibited a lower DTI-ALPS and poorer odor identification, semantic fluency and processing speed relative to HC. The DTI-ALPS positively correlated with cognitive performance, olfactory function and amygdalar, hippocampal, brainstem and diencephalic volumes, and negatively with age in iRBD. Perivascular glymphatic activity is compromised in iRBD and is associated with brain atrophy and clinical risk factors of progression to alpha-synucleinopathies, supporting the potential of the DTI-ALPS index as an early imaging neurodegeneration marker.
dc.format.extent10 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec759111
dc.identifier.issn2373-8057
dc.identifier.pmid40268930
dc.identifier.urihttps://hdl.handle.net/2445/226938
dc.language.isoeng
dc.publisherSpringer Nature
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1038/s41531-025-00942-z
dc.relation.ispartofnpj Parkinson's Disease, 2025, vol. 11, num.1, p. 87
dc.relation.urihttps://doi.org/10.1038/s41531-025-00942-z
dc.rightscc-by (c) Roura I et al., 2025
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.classificationNeurologia
dc.subject.classificationDegeneració (Patologia)
dc.subject.classificationCervell
dc.subject.otherNeurology
dc.subject.otherDegeneration (Pathology)
dc.subject.otherBrain
dc.titleClinical and brain volumetric correlates of decreased DTI-ALPS, suggestive of local glymphatic dysfunction, in iRBD
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
896093.pdf
Mida:
1.57 MB
Format:
Adobe Portable Document Format